13F filer · CIK 1822947
Ally Bridge Group (NY) LLC
NEW YORK, NY · filing since Q4 2020 · last filing Aug 14, 2026
Reported value
$113.1M
$-10.7M vs prior
Positions
25
New / sold out
12 / 14
Added / reduced
2 / 9
Turnover
59.4%
buys $70.3M · sells $88.6M
Top-10 weight
70.5%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | DEFINIUM THERAPEUTICS INCCALL | +400,000 | – | +$18.8M |
| New | ABIVAX SACALL | +125,000 | – | +$16.7M |
| New | FIRST TRACKS BIOTHERAPEUTICS | +284,287 | – | +$5.7M |
| New | AXSOME THERAPEUTICS INC | +16,493 | – | +$4.0M |
| New | ASSEMBLY BIOSCIENCES INC | +140,000 | – | +$3.8M |
| New | CLIMB BIO INC | +249,172 | – | +$3.2M |
| New | KURA ONCOLOGY INC | +290,000 | – | +$3.2M |
| Added | MINERVA NEUROSCIENCES INC | +520,302 | +31.4% | +$2.9M |
| New | AVALO THERAPEUTICS INC | +150,000 | – | +$2.8M |
| Added | PROMIS NEUROSCIENCES INC | +206,100 | +49.8% | +$2.7M |
4 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | PRAXIS PRECISION MEDICINES I | -32,810 | -100.0% | $-10.6M |
| Sold out | SOLENO THERAPEUTICS INC | -200,000 | -100.0% | $-6.7M |
| Sold out | SOLENO THERAPEUTICS INCPUT | -200,000 | -100.0% | $-6.7M |
| Reduced | OVID THERAPEUTICS INC | -2,193,898 | -77.8% | $-5.9M |
| Sold out | COMPASS PATHWAYS PLC | -1,045,000 | -100.0% | $-5.8M |
| Sold out | TARSUS PHARMACEUTICALS INC | -80,859 | -100.0% | $-5.7M |
| Sold out | COMPASS THERAPEUTICS INCCALL | -1,000,000 | -100.0% | $-5.3M |
| Reduced | SOLID BIOSCIENCES INC | -511,015 | -66.6% | $-5.1M |
| Sold out | UNIQURE NVCALL | -300,000 | -100.0% | $-4.9M |
| Reduced | UROGEN PHARMA LTD | -132,941 | -65.8% | $-4.9M |
13 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | DEFINIUM THERAPEUTICS INCCALLCOM SHS | 400,000 | $18.8M | 16.64% |
| 2 | ABIVAX SACALLSPONSORED ADS | 125,000 | $16.7M | 14.73% |
| 3 | MINERVA NEUROSCIENCES INCCOM NEW | 2,175,802 | $12.1M | 10.68% |
| 4 | PROMIS NEUROSCIENCES INCCOM SHS | 620,319 | $8.2M | 7.22% |
| 5 | FIRST TRACKS BIOTHERAPEUTICSORD SHS | 284,287 | $5.7M | 5.06% |
| 6 | AXSOME THERAPEUTICS INCCOM | 16,493 | $4.0M | 3.57% |
| 7 | ASSEMBLY BIOSCIENCES INCCOM NEW | 140,000 | $3.8M | 3.40% |
| 8 | WHITEHAWK THERAPEUTICS INCCOM | 817,939 | $3.7M | 3.31% |
| 9 | EDGEWISE THERAPEUTICS INCCOM | 83,300 | $3.4M | 2.99% |
| 10 | CLIMB BIO INCCOM | 249,172 | $3.2M | 2.87% |
15 more rows. Subscribe for $29/month to see every row, download the data and use the API.